CLSI MM12 A : 1ED 2006

Name: CLSI MM12 A : 1ED 2006
Brand: CLSI

Withdrawn

DIAGNOSTIC NUCLEIC ACID MICROARRAYS

Withdrawn date

03-28-2016

Published date

01-12-2013

Publisher

Clinical Laboratory Standards Institute

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Method Overview
6 Analytical Methods
7 Genetic Data Analysis
8 Gene Expression Data Analysis
9 Validation
10 Quality Control/Quality Assurance
References
Appendix A - Gene Expression Data Analysis
Appendix B - Validation
Appendix References
Summary of Consensus/Delegate Comments and Committee
Responses
The Quality System Approach
Related CLSI/NCCLS Publications

Provides recommendations for many aspects of the array process including: a method overview; nucleic acid extraction; the preparation, handling, and assessment of genetic material; quality control; analytic validation; and interpretation and reporting of results.

DevelopmentNote	Supersedes NCCLS MM12 P (07/2006)
DocumentType	Miscellaneous Product
PublisherName	Clinical Laboratory Standards Institute
Status	Withdrawn
Supersedes	CLSI MM12 P : 1ED 2005

CLSI MM22 A : 1ED 2014	MICROARRAYS FOR DIAGNOSIS AND MONITORING OF INFECTIOUS DISEASES
CLSI MM19 P : 1ED 2011	ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
ISO 16142-2:2017	Medical devices — Recognized essential principles of safety and performance of medical devices — Part 2: General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards
CLSI MM1 A3 : 3ED 2012	MOLECULAR METHODS FOR CLINICAL GENETICS AND ONCOLOGY TESTING
CLSI MM17 P : 1ED 2007	VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS
ANSI/AAMI/ISO 16142-2:2017	MEDICAL DEVICES - RECOGNIZED ESSENTIAL PRINCIPLES OF SAFETY AND PERFORMANCE OF MEDICAL DEVICES - PART 2: GENERAL ESSENTIAL PRINCIPLES AND ADDITIONAL SPECIFIC ESSENTIAL PRINCIPLES FOR ALL IVD MEDICAL DEVICES AND GUIDANCE ON THE SELECTION OF STANDARDS
CLSI MM5 A2 : 2ED 2012	NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY
CLSI MM17 A : 1ED 2008	VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS
CLSI MM23 : 1ED 2015	MOLECULAR DIAGNOSTIC METHODS FOR SOLID TUMORS (NONHEMATOLOGICAL NEOPLASMS)
CLSI MM21 : 1ED 2015	GENOMIC COPY NUMBER MICROARRAYS FOR CONSTITUTIONAL GENETIC AND ONCOLOGY APPLICATIONS
BS ISO 16142-2:2017	Medical devices. Recognized essential principles of safety and performance of medical devices General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards
CLSI MM19 A : 1ED 2011	ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
CLSI MM16 A : 1ED 2006	USE OF EXTERNAL RNA CONTROLS IN GENE EXPRESSION ASSAYS
CLSI MM20 A : 1ED 2012	QUALITY MANAGEMENT FOR MOLECULAR GENETIC TESTING

CLSI C24 A2 : 2ED 99	STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENTS: PRINCIPLES AND DEFINITIONS
CLSI GP29 A : 1ED 2002	VALIDATION OF LABORATORY TESTS WHEN PROFICIENCY TESTING IS NOT AVAILABLE
CLSI MM6 A : 1ED 2003	QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES
CLSI EP10 A2 : 2ED 2002	PRELIMINARY EVALUATION OF QUANTITATIVE CLINICAL LABORATORY METHODS
CLSI MM14 A : 1ED 2005	PROFICIENCY TESTING (EXTERNAL QUALITY ASSESSMENT) FOR MOLECULAR METHODS
CLSI MM1 A : 1ED 2000	MOLECULAR DIAGNOSTIC METHODS FOR GENETIC DISEASES
CLSI MM2 A2 : 2ED 2002	IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE REARRANGEMENT ASSAYS
CLSI MM3 A2 : 2ED 2006	MOLECULAR DIAGNOSTIC METHODS FOR INFECTIOUS DISEASES
CLSI MM5 A : 1ED 2003	NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY